|
注册号: Registration number: |
ChiCTR2600125258 |
|
最近更新日期: Date of Last Refreshed on: |
2026-05-24 16:56:53 |
|
注册时间: Date of Registration: |
2026-05-24 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
EICU成人患者CVC堵塞预防方案的构建与初步应用 |
|
Public title: |
Construction and Preliminary Application of a Prevention Protocol for Central Venous Catheter Occlusion in Adult Patients in the Emergency Intensive Care Unit |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
EICU成人患者CVC堵塞预防方案的构建与初步应用 |
|
Scientific title: |
Construction and Preliminary Application of a Prevention Protocol for Central Venous Catheter Occlusion in Adult Patients in the Emergency Intensive Care Unit |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
黄乐娇 |
研究负责人: |
毛世芳 |
|
Applicant: |
Huang Lejiao |
Study leader: |
Mao Shifang |
|
申请注册联系人电话: Applicant telephone: |
+86 187 8496 3561 |
研究负责人电话:
Study leader's |
+86 187 8496 3561 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
18784963561@163.com |
研究负责人电子邮件: Study leader's E-mail: |
2635695595@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
西南医科大学 |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
|
|
申请注册联系人通讯地址: |
中国四川省泸州市龙马潭区香林路1段1号 |
研究负责人通讯地址: |
中国四川省泸州市江阳区太平街25号 |
|
Applicant address: |
1 Section 1, Xianglin Road, Longmatan District, Luzhou, Sichuan, China |
Study leader's address: |
25 Taiping Street, Jiangyang District, Luzhou, Sichuan, China |
|
申请注册联系人邮政编码: Applicant postcode: |
646000 |
研究负责人邮政编码: Study leader's postcode: |
646000 |
|
申请人所在单位: |
西南医科大学 |
||
|
Applicant's institution: |
Southwest Medical University |
||
|
研究负责人所在单位: |
西南医科大学附属医院 |
||
|
Affiliation of the Leader: |
The Affiliated Hospital of Southwest Medical University |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
KY2025456 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
西南医科大学附属医院临床试验伦理委员会 |
||
|
Name of the ethic committee: |
Clinical Trial Ethics Committee of the Affiliated Hospital of Southwest Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2025-08-29 00:00:00 | ||
|
伦理委员会联系人: |
张增瑞 |
||
|
Contact Name of the ethic committee: |
Zhang Zengrui |
||
|
伦理委员会联系地址: |
中国四川省泸州市江阳区太平街25号 |
||
|
Contact Address of the ethic committee: |
25 Taiping Street, Jiangyang District, Luzhou, Sichuan, China |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 830 316 5273 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
西南医科大学附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
The Affiliated Hospital of Southwest Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
中国四川省泸州市江阳区太平街25号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
25 Taiping Street, Jiangyang District, Luzhou, Sichuan, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自筹 |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-funded |
||||||||||||||||||||||
|
研究疾病: |
中心静脉导管堵塞 |
||||||||||||||||||||||
|
Target disease: |
Central Venous Catheter Occlusion |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
1. 基于证据总结与Meta分析结果,初步构建《EICU成人患者中心静脉导管堵塞预防方案》初稿,并通过专家会议法形成《EICU成人患者中心静脉导管堵塞预防方案》; 2. 初步验证《EICU成人患者中心静脉导管堵塞预防方案》在降低EICU成人患者中心静脉导管堵塞发生率、延长导管通畅时间方面的临床效果。 |
||||||||||||||||||||||
|
Objectives of Study: |
1. To initially construct the first draft of the Prevention Protocol for Central Venous Catheter (CVC) Occlusion in Adult Patients in the Emergency Intensive Care Unit (EICU) based on evidence summaries and Meta-analysis results, and to finalize the protocol through expert panel meetings; 2. To preliminarily validate the clinical effectiveness of the Prevention Protocol for CVC Occlusion in Adult Patients in the EICU in reducing the incidence of CVC occlusion and prolonging catheter patency time among adult patients in the EICU. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
1. 以血液透析为目的置入的CVC; 2. 置管侧肢体同时存在其他静脉通路,如PICC; 3. 研究期间发生全身重度感染者; 4. 研究中途死亡的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. CVCs inserted for the purpose of hemodialysis; 2. Presence of other venous access, such as a PICC, in the same limb as the catheter insertion site; 3. Patients who develop severe systemic infection during the study period; 4. Patients who die during the course of the study. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-05-01 00:00:00至 To 2026-09-30 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-05-24 00:00:00 至 To 2026-07-15 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
不公开/Private |
|
盲法: |
|
|
Blinding: |
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
否 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
none |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
否 |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
none |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |